Fox Run Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$206K Buy
2024
Q1
Sell
2023
Q4
$717K Buy
2023
Q3
Sell
2023
Q2
$771K Buy
2023
Q1
Sell
2022
Q4
$316K Sell
2022
Q3
$343K Buy